BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 67 filers reported holding BLUEBIRD BIO INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $111,874,000 | +11.9% | 1,813,191 | +22.9% | 0.02% | 0.0% |
| Q3 2016 | $100,002,000 | +66.6% | 1,475,395 | +6.4% | 0.02% | +61.5% |
| Q2 2016 | $60,010,000 | +83.3% | 1,386,229 | +80.0% | 0.01% | +62.5% |
| Q1 2016 | $32,731,000 | -33.9% | 770,134 | -0.1% | 0.01% | -27.3% |
| Q4 2015 | $49,523,000 | -31.0% | 771,142 | -8.1% | 0.01% | -42.1% |
| Q3 2015 | $71,768,000 | -37.9% | 838,902 | +22.3% | 0.02% | -32.1% |
| Q2 2015 | $115,515,000 | -12.8% | 686,076 | -37.4% | 0.03% | -12.5% |
| Q1 2015 | $132,445,000 | +52.2% | 1,096,674 | +15.6% | 0.03% | +45.5% |
| Q4 2014 | $87,029,000 | +179.9% | 948,851 | +9.5% | 0.02% | +144.4% |
| Q3 2014 | $31,094,000 | +6.1% | 866,616 | +14.0% | 0.01% | +12.5% |
| Q2 2014 | $29,310,000 | +166.6% | 759,913 | +57.2% | 0.01% | +166.7% |
| Q1 2014 | $10,996,000 | +13.6% | 483,547 | +4.8% | 0.00% | 0.0% |
| Q4 2013 | $9,683,000 | +86.5% | 461,513 | +139.6% | 0.00% | +50.0% |
| Q3 2013 | $5,192,000 | – | 192,587 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AlpInvest Partners B.V. | 46,264 | $3,958,000 | 7.80% |
| RTW INVESTMENTS, LP | 151,594 | $12,969,000 | 4.03% |
| APIS CAPITAL ADVISORS, LLC | 30,870 | $2,640,000 | 3.65% |
| Parametrica Management Ltd | 4,084 | $349,000 | 2.20% |
| Eventide Asset Management | 419,600 | $35,897,000 | 2.09% |
| RA Capital Management | 167,367 | $14,318,000 | 2.06% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 483,000 | $41,321,000 | 1.60% |
| Taylor Wealth Management Partners | 38,184 | $3,267,000 | 1.58% |
| Orbimed Advisors | 1,188,900 | $101,710,000 | 1.03% |
| CABOT WEALTH MANAGEMENT INC | 34,195 | $2,925,000 | 0.81% |